SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Muhammad Ali

PatientMuhammad Ali
Date of birth1972-01-17
IdentifiersMRN HR-BX001-SYN; SSN (made up) 000-01-7724
Document date2026-02-10
AuthorCeleste Moreau, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for establishing primary care for Parkinson's disease: motor, non-motor, fall-risk, and orthostatic assessment. [S]

Objective

Hemoglobin: 14.6 g/dL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 1.02 mg/dL; eGFR: 87 mL/min/1.73 m²; Glucose: 92 mg/dL; Calcium: 9.5 mg/dL; Vitamin B12: 512 pg/mL; TSH: 1.8 mIU/L; MoCA: 27; PHQ-9: 3. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-02-10Body height191cmS
2026-02-10Body weight102kgS
2026-02-10Body mass index (BMI) [Ratio]28kg/m2S
2026-02-10Systolic blood pressure128mm[Hg]S
2026-02-10Diastolic blood pressure78mm[Hg]S
2026-02-10Heart rate72/minS
2026-02-10Respiratory rate14/minS
2026-02-10Body temperature36.7CelS
2026-02-10Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-10Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-16.6 g/dLNormalS
2026-02-10Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-02-10Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-02-10Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-02-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-10Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-02-10Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
2026-02-10Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma512pg/mL232-1245 pg/mLNormalS
2026-02-10Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.45-4.5 mIU/LNormalS
2026-02-10Total score [MoCA]27{score}S
2026-02-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times dailyOne tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m.Oral route2014-10-01 to 2026-03-10completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuationsactiveconfirmed G20.A1S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic.
Hypokinetic dysarthria with soft speech due to Parkinson's diseaseactiveconfirmed R47.1S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic.

Assessment

Plan of Treatment